1. Home
  2. SDST vs PFSA Comparison

SDST vs PFSA Comparison

Compare SDST & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stardust Power Inc.

SDST

Stardust Power Inc.

N/A

Current Price

$0.09

Market Cap

1.5M

Sector

Finance

ML Signal

N/A

PFSA

Profusa Inc.

N/A

Current Price

$1.72

Market Cap

1.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SDST
PFSA
Founded
2022
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5M
1.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SDST
PFSA
Price
$0.09
$1.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 29.7M
2.9M
Earning Date
11-12-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$0.05
52 Week High
$7.67
$28.32

Technical Indicators

Market Signals
Indicator
SDST
PFSA
Relative Strength Index (RSI) 25.49 44.62
Support Level N/A $1.58
Resistance Level $0.36 $2.35
Average True Range (ATR) 0.03 0.49
MACD 0.02 -0.01
Stochastic Oscillator 3.34 4.81

Price Performance

Historical Comparison
SDST
PFSA

About SDST Stardust Power Inc.

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: